Study S002594

Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium-glucose Cotransporter-2 Inhibitors (SGLT2is) Combination Therapy and Major Adverse Cardiovascular Events After Acute Myocardial Infarction: an Observational Study in Patients with Type 2 Diabetes.

ClinicalTrials.gov record

Registration

Registration: NCT06017544
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 257
Start: 2017-01-01
Primary completion: 2024-06-01
Lead sponsor: University of Campania Luigi Vanvitelli
Conditions: Diabetes Mellitus, Type 2; Myocardial Infarction
Interventions: PROCEDURE:PCI
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

MACE [12 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0006178	GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes. Marfella R, Cardiovascular diabetology	2024	Nonrandomized study	PMID 38184582 DOI	cites ClinicalTrials.gov:NCT06017544; registry reference DERIVED:38184582